Perspectives of individuals with sickle cell disease on barriers to care.

<h4>Introduction</h4>Sickle cell disease (SCD) is an inherited hemoglobinopathy that predominantly affects African Americans in the United States. The disease is associated with complications leading to high healthcare utilization rates, including emergency department (ED) visits and hos...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Shannon Phillips, Yumei Chen, Rita Masese, Laurence Noisette, Kasey Jordan, Sara Jacobs, Lewis L Hsu, Cathy L Melvin, Marsha Treadwell, Nirmish Shah, Paula Tanabe, Julie Kanter
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Online Access:	https://doi.org/10.1371/journal.pone.0265342

Similar Items

Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers' perspective.
by: Rita Vanessa Masese, et al.
Published: (2019-01-01)

Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA
by: Robert Gibson, et al.
Published: (2021-11-01)

Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry
by: Gustavo G. Mendez, et al.
Published: (2024-03-01)

Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease
by: Kristen E. Howell, et al.
Published: (2023-08-01)

Current Methods of Newborn Screening Follow-Up for Sickle Cell Disease Are Highly Variable and without Quality Assurance: Results from the ENHANCE Study
by: Najibah Galadanci, et al.
Published: (2024-03-01)

Challenges of Engaging Primary Care Providers in Specialized Telementoring Education About Sickle Cell Disease for Sickle Cell Specialists: Results from the Sickle Cell Disease Training and Mentoring Program for Primary Care Providers (STAMP) Project ECHO
by: Lisa M. Shook, DHPE, MA, MCHES, et al.
Published: (2025-02-01)

“The project did not come to us with a solution”: Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease
by: Ana A. Baumann, et al.
Published: (2023-11-01)

Recruitment Strategies in the Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization Study (meSH): Multicenter Survey Study
by: Chinonyelum Nwosu, et al.
Published: (2024-04-01)

P-080: IMPLEMENTATION OF SCREENING TOOL IN SICKLE CELL CLINIC TO IDENTIFY SOCIAL DETERMINANTS OF HEALTH
by: PATEL J., et al.
Published: (2022-08-01)

Motivators and Barriers to Physical Activity among Youth with Sickle Cell Disease: Brief Review
by: Olalekan Olatokunbo Olorunyomi, et al.
Published: (2022-04-01)

Sickle cell disease is a global prototype for integrative research and healthcare
by: Charmaine D. M. Royal, et al.
Published: (2021-03-01)

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults study
by: Julie Kanter, et al.
Published: (2024-11-01)

National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease
by: Stephanie Howe Guarino, et al.
Published: (2025-09-01)

High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective Study
by: Julie Kanter, et al.
Published: (2019-10-01)

Factors associated with left ventricular hypertrophy in children with sickle cell disease: results from the DISPLACE study
by: Najibah A. Galadanci, et al.
Published: (2022-04-01)

Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study
by: Nirmish Shah, et al.
Published: (2020-06-01)

Dissemination of Evidence-Based Recommendations for Sickle Cell Disease to Primary Care and Emergency Department Providers in North Carolina: A Cost Benefit Analysis
by: Paula Tanabe, et al.
Published: (2021-04-01)

Tracking Telehealth Needs for Individuals With Sickle Cell Disease Through the COVID‐19 Pandemic: A Cross‐Sectional Survey Study
by: Marsha Treadwell, et al.
Published: (2024-11-01)

PB2504: USE OF CONSUMER WEARABLES TO MONITOR AND PREDICT PAIN IN PATIENTS WITH SICKLE CELL DISEASE
by: Caroline Vuong, et al.
Published: (2023-08-01)

The effect of an adapted digital mental health intervention for sickle cell disease on engagement: a pilot randomized controlled trial
by: Emily V. Nardo, et al.
Published: (2023-12-01)

Improving Pain Assessment Using Vital Signs and Pain Medication for Patients With Sickle Cell Disease: Retrospective Study
by: Swati Padhee, et al.
Published: (2022-06-01)

Use of consumer wearables to monitor and predict pain in patients with sickle cell disease
by: Caroline Vuong, et al.
Published: (2023-10-01)

Impaired pulmonary endothelial barrier function in sickle cell mice
by: Nagavedi S. Umapathy, et al.
Published: (2017-01-01)

Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania
by: Manase Kilonzi, et al.
Published: (2021-11-01)

Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis
by: George Joseph, et al.
Published: (2020-09-01)

5612576 DEVELOPMENT AND IMPLEMENTATION OF NEUROPSYCHOLOGICAL SCREENING AND EVALUATION SERVICES FOR ADULTS LIVING WITH SICKLE CELL DISEASE: FINDINGS FROM A TWO-YEAR PILOT PROGRAM
by: J. Cavazos, et al.
Published: (2023-04-01)

Uniqueness for the Camassa–Holm equation with non-homogeneous boundary conditions
by: Noisette, Florent
Published: (2025-03-01)

Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study
by: Nirmish Shah, et al.
Published: (2019-05-01)

Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study
by: Nirmish Shah, et al.
Published: (2019-10-01)

Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease
by: Lori C. Jordan, et al.
Published: (2024-06-01)

Predicting Pain in People With Sickle Cell Disease in the Day Hospital Using the Commercial Wearable Apple Watch: Feasibility Study
by: Rebecca Sofia Stojancic, et al.
Published: (2023-03-01)

PB2524: TRIAL IN PROGRESS: THE HIBISCUS-KIDS STUDY, A SINGLE-ARM, OPEN-LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
by: Raffaella Colombatti, et al.
Published: (2023-08-01)

Endari treatment ameliorates sickle cell-related disruption in intestinal barrier functions and is associated with prolonged survival in sickle cell mice
by: Elio Haroun, et al.
Published: (2024-12-01)

PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS
by: Miguel Abboud, et al.
Published: (2023-08-01)

Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study
by: Sherif M Badawy, et al.
Published: (2022-10-01)

PI-01: GRNDAD AND COUSIN: INVESTIGATOR-INITIATED COLLABORATIONS TO IMPROVE CARE IN SICKLE CELL DISEASE
by: LITTLE J., et al.
Published: (2022-08-01)

Implementing ASH’s guidelines for acute medical care for incarcerated children and adults with sickle cell disease
by: Michael R. DeBaun, et al.
Published: (2025-06-01)

Know your blood: Addressing barriers to preconceptual screening for sickle cell disease
by: Ernel Boadi, et al.
Published: (2025-08-01)

Barriers to Care for Adults With Sickle Cell Disease: A Qualitative Descriptive Study
by: Chanell Grismore, et al.
Published: (2025-06-01)

Spatiotemporal Dysfunction of the Vascular Permeability Barrier in Transgenic Mice with Sickle Cell Disease
by: Samit Ghosh, et al.
Published: (2012-01-01)